Anatomy Review: The Heart
... Study Questions on the Intrinsic Conduction System: 1. What is the purpose of the intrinsic conduction system of the heart? 2. What type of cells are present in the intrinsic conduction system of the heart? 3. List the six areas within the heart where autorhythmic cells are found. 4. Match the six a ...
... Study Questions on the Intrinsic Conduction System: 1. What is the purpose of the intrinsic conduction system of the heart? 2. What type of cells are present in the intrinsic conduction system of the heart? 3. List the six areas within the heart where autorhythmic cells are found. 4. Match the six a ...
paccocath isr - Clinical Trial Results
... • Treatment of coronary in-stent restenosis is hampered by high incidence of recurrent in-stent restenosis. • Multiple studies have shown the benefit of drug-eluting stents in preventing restenosis in de novo lesions, but only one randomized trial, ISAR-DESIRE, has been conducted for patients with p ...
... • Treatment of coronary in-stent restenosis is hampered by high incidence of recurrent in-stent restenosis. • Multiple studies have shown the benefit of drug-eluting stents in preventing restenosis in de novo lesions, but only one randomized trial, ISAR-DESIRE, has been conducted for patients with p ...
Reducing Heart Failure Hospital Readmissions: Are You
... 2. Identify best practices that can be implemented to reduce avoidable hospital readmissions. 3. Describe the physiology and pathophysiology of heart failure. 4. Discuss the clinical assessment and classifications of the patient with heart failure. 5. Discuss the indications, dosing, adverse effects ...
... 2. Identify best practices that can be implemented to reduce avoidable hospital readmissions. 3. Describe the physiology and pathophysiology of heart failure. 4. Discuss the clinical assessment and classifications of the patient with heart failure. 5. Discuss the indications, dosing, adverse effects ...
Cardiovascular System - Myotonic Dystrophy Foundation
... avoided since sudden death has been associated with rapidly elevated heartbeat. Congestive heart failure should be managed with conventional treatments. The cautious use of anti-myotonic medications and general anesthetics is also warranted, as they can elevate the risk of cardiorespiratory complica ...
... avoided since sudden death has been associated with rapidly elevated heartbeat. Congestive heart failure should be managed with conventional treatments. The cautious use of anti-myotonic medications and general anesthetics is also warranted, as they can elevate the risk of cardiorespiratory complica ...
HERMAN K. GOLD, ROBERT C. LEINBACH and CHARLES A. SANDERS 1972;46:839-845
... example, could produce directionally similar results. It is generally believed that nitroglycerin is contraindicated in acute myocardial infarction because of the potential deleterious effects of a decrease in coronary perfusion pressure and a reflex rise in heart rate. In the present study, during ...
... example, could produce directionally similar results. It is generally believed that nitroglycerin is contraindicated in acute myocardial infarction because of the potential deleterious effects of a decrease in coronary perfusion pressure and a reflex rise in heart rate. In the present study, during ...
prediction and prevention of sudden cardiac death in - Heart
... ventricular arrhythmia, both the proportion of patients who had received an ICD therapy and the sudden death rates were comparable between patients with moderate or severe LV dysfunction (LVEF . 30% and , 30%, respectively).w6 ...
... ventricular arrhythmia, both the proportion of patients who had received an ICD therapy and the sudden death rates were comparable between patients with moderate or severe LV dysfunction (LVEF . 30% and , 30%, respectively).w6 ...
Early and mid-term outcomes of percutaneous mitral valve repair
... symptomatic MR. Baseline characteristics, perioperative results, mid-term survival, major adverse cerebrovascular and cardiac events (MACCE), and re-hospitalisation were compared in patients with LES <20% (n=30) and ≥20% (n=55). Overall LES was 24±12 (range 2.5-56.3) and STS-score 12±7 (range 1.2-31 ...
... symptomatic MR. Baseline characteristics, perioperative results, mid-term survival, major adverse cerebrovascular and cardiac events (MACCE), and re-hospitalisation were compared in patients with LES <20% (n=30) and ≥20% (n=55). Overall LES was 24±12 (range 2.5-56.3) and STS-score 12±7 (range 1.2-31 ...
in heart failure Prediction and prevention of sudden cardiac death
... ventricular arrhythmia, both the proportion of patients who had received an ICD therapy and the sudden death rates were comparable between patients with moderate or severe LV dysfunction (LVEF . 30% and , 30%, respectively).w6 ...
... ventricular arrhythmia, both the proportion of patients who had received an ICD therapy and the sudden death rates were comparable between patients with moderate or severe LV dysfunction (LVEF . 30% and , 30%, respectively).w6 ...
PDF - Bentham Open
... patients with HFpEF is the aggressive treatment of noncardiac comorbidities [18,58,59]. Indeed, an important aspect of ventricular–arterial coupling is the detrimental impact of AS on LV diastolic function in different populations: in patients with chronic obstructive pulmonary disease (COPD), HTN, ...
... patients with HFpEF is the aggressive treatment of noncardiac comorbidities [18,58,59]. Indeed, an important aspect of ventricular–arterial coupling is the detrimental impact of AS on LV diastolic function in different populations: in patients with chronic obstructive pulmonary disease (COPD), HTN, ...
Brain Natriuretic Peptide (BNP) Level
... B-type natriuretic peptide (BNP) is a cardiac neurohormone produced mainly in the left ventricle. It is secreted in response to ventricular volume expansion and pressure overload, factors often found in congestive heart failure (CHF). Used in conjunction with other clinical information, rapid measur ...
... B-type natriuretic peptide (BNP) is a cardiac neurohormone produced mainly in the left ventricle. It is secreted in response to ventricular volume expansion and pressure overload, factors often found in congestive heart failure (CHF). Used in conjunction with other clinical information, rapid measur ...
Cardiovascular disease in patients with chronic kidney disease
... events in patients with CKD,1 with approximately 40–50% of the mortality of patients with stage 5 CKD on renal replacement treatment being attributed to CVD.2 For dialysis patients, the post-myocardial infarction (MI) 1- and 2-year mortality rates are 61% and 75%, respectively.3 Furthermore, there i ...
... events in patients with CKD,1 with approximately 40–50% of the mortality of patients with stage 5 CKD on renal replacement treatment being attributed to CVD.2 For dialysis patients, the post-myocardial infarction (MI) 1- and 2-year mortality rates are 61% and 75%, respectively.3 Furthermore, there i ...
Managing Hyperlipidemia: An Evidence
... cardiovascular deaths and total cardiovascular events were reduced by 11 percent, mostly by reduction in non-fatal MI and reduced coronary revascularization. Most concerning was a non-significant increase in cardiovascular deaths. Diabetes is a cardiovascular risk equivalent under the NCEP lipid tre ...
... cardiovascular deaths and total cardiovascular events were reduced by 11 percent, mostly by reduction in non-fatal MI and reduced coronary revascularization. Most concerning was a non-significant increase in cardiovascular deaths. Diabetes is a cardiovascular risk equivalent under the NCEP lipid tre ...
White Paper: Common Complications Associated with Left
... Ventricular assist devices function to reduce myocardial work by reducing ventricular preload while maintaining systemic circulation. The devices may be extracorporeal, paracorporeal, implantable with percutaneous power support, or fully implantable, and may provide continuous or pulsatile flow. Ven ...
... Ventricular assist devices function to reduce myocardial work by reducing ventricular preload while maintaining systemic circulation. The devices may be extracorporeal, paracorporeal, implantable with percutaneous power support, or fully implantable, and may provide continuous or pulsatile flow. Ven ...
CRT Overview - February 2004
... CRT device: – Moderate to severe HF (NYHA Class III/IV) patients ...
... CRT device: – Moderate to severe HF (NYHA Class III/IV) patients ...
To Article
... and accurate test for ischemia. The current study investigates the accuracy of a non-invasive and inexpensive technique: the analysis of high-frequency components of the QRS complex (HFQRS). The ECG changes most recognized and described (such as ST-deviation) occur in the frequency range below 100 H ...
... and accurate test for ischemia. The current study investigates the accuracy of a non-invasive and inexpensive technique: the analysis of high-frequency components of the QRS complex (HFQRS). The ECG changes most recognized and described (such as ST-deviation) occur in the frequency range below 100 H ...
PRACTICE Matters T C
... patients with a history of atherosclerotic vascular disease, diabetes mellitus, or hypertension and associated cardiovascular risk factors. ...
... patients with a history of atherosclerotic vascular disease, diabetes mellitus, or hypertension and associated cardiovascular risk factors. ...
Cardialysis Imaging Core Lab in TAVI Clinical Trials
... the procedure into the spotlight. However, there are several unresolved safety issues, including postprocedural paravalvular leak, atrioventricular heart block, vascular complications, and stroke. Multi-modality cardiac imaging might help to overcome these safety concerns by minimising TAVI complica ...
... the procedure into the spotlight. However, there are several unresolved safety issues, including postprocedural paravalvular leak, atrioventricular heart block, vascular complications, and stroke. Multi-modality cardiac imaging might help to overcome these safety concerns by minimising TAVI complica ...
MLC-1 (MYOSIN LIGHT CHAINS-1) IN DIFFERENTIAL DIAGNOSIS
... often found in myocardial dysfunction. Moreover, these structural changes may accelerate dysfunction of ventricles and enhance the filling pressure6, 8–10. Another reason may be MLC-1 gene overexpression. This factor may lead to an oversynthesis of protein in myocardial cells and its transfer into ci ...
... often found in myocardial dysfunction. Moreover, these structural changes may accelerate dysfunction of ventricles and enhance the filling pressure6, 8–10. Another reason may be MLC-1 gene overexpression. This factor may lead to an oversynthesis of protein in myocardial cells and its transfer into ci ...
August CE Angina, Acute MI, Stroke
... Diagnosing Cardiac Problems Patient history of events 12 lead EKG analysis – changes over hours & days Large peaked T waves, then ST elevation, then negative T waves, then pathological Q wave development ...
... Diagnosing Cardiac Problems Patient history of events 12 lead EKG analysis – changes over hours & days Large peaked T waves, then ST elevation, then negative T waves, then pathological Q wave development ...
Pathogenesis of cardiac failure
... rises and the increased pressure is often transmitted to the pulmonary system, leading to pulmonary congestion and dyspnoea. This compensatory mechanism occurs in an effort to enhance ventricular filling and to maintain cardiac output. The predisposing conditions associated with diastolic heart fail ...
... rises and the increased pressure is often transmitted to the pulmonary system, leading to pulmonary congestion and dyspnoea. This compensatory mechanism occurs in an effort to enhance ventricular filling and to maintain cardiac output. The predisposing conditions associated with diastolic heart fail ...
Chronic Angina Pectoris - International Neuromodulation Society
... improvement. In a group of patients with a high operative CABS risk, SCS even showed lower rates of mortality, cerebrovascular morbidity and re-hospitalization. In addition, SCS was shown to be comparable to the other active comparators. Compared to the sham SCS, active SCS resulted in significant i ...
... improvement. In a group of patients with a high operative CABS risk, SCS even showed lower rates of mortality, cerebrovascular morbidity and re-hospitalization. In addition, SCS was shown to be comparable to the other active comparators. Compared to the sham SCS, active SCS resulted in significant i ...
The value of invasive monitoring in shock patients
... The use of pulmonary artery catheters probably needs re‐evaluation but they should not be banned Connors et al retrospectively reviewed 5735 critically ill patients. The results strongly suggest that in all groups mortality, the length of intensive care, and hospital costs were higher when a pulm ...
... The use of pulmonary artery catheters probably needs re‐evaluation but they should not be banned Connors et al retrospectively reviewed 5735 critically ill patients. The results strongly suggest that in all groups mortality, the length of intensive care, and hospital costs were higher when a pulm ...
Role of Cardiac Rehabilitation in Secondary Prevention
... • Improved CAD risk factor control • Reduced depression Though originally designed for coronary artery disease patients, there is accumulating evidence that patients with other cardiac diseases will also benefit from cardiac rehabilitation ...
... • Improved CAD risk factor control • Reduced depression Though originally designed for coronary artery disease patients, there is accumulating evidence that patients with other cardiac diseases will also benefit from cardiac rehabilitation ...
Coronary artery imaging with multidetector computed
... benefit from evaluation of coronary anatomy. There are currently no data supporting different recommendations for coronary CTA. Moreover, patients with high probability of CAD are not likely to benefit from CTA because this would only confirm the need for invasive, diagnostic/therapeutic catheteriza ...
... benefit from evaluation of coronary anatomy. There are currently no data supporting different recommendations for coronary CTA. Moreover, patients with high probability of CAD are not likely to benefit from CTA because this would only confirm the need for invasive, diagnostic/therapeutic catheteriza ...
N-terminal Pro-brain Natriuretic Peptide as a Prognostic Predictor in
... 50%, n = 26). Plasma NT-proBNP levels and LVEF by bedside echocardiography were measured within 24 hours of admission. Combined adverse cardiac events (death or heart failure) and all-cause mortality were monitored. Results: The levels of plasma NT-proBNP in NS-CHF and S-CHF groups were 6055.7 ± 503 ...
... 50%, n = 26). Plasma NT-proBNP levels and LVEF by bedside echocardiography were measured within 24 hours of admission. Combined adverse cardiac events (death or heart failure) and all-cause mortality were monitored. Results: The levels of plasma NT-proBNP in NS-CHF and S-CHF groups were 6055.7 ± 503 ...